Birkenstock Holding plc (BIRK) Stock Price & How to Invest

Birkenstock makes the cork-and-latex footbed sandals and clogs it has been producing since 1774, sold under silhouette names most buyers know better than the ticker: Arizona, Gizeh, Madrid, and the Boston clog that has become the growth engine. Roughly 100% of footwear units are produced in the company's own German factories (Görlitz, St. Katharinen, Bernstadt and Pasewalk), which is unusual in footwear and is the reason gross margin sits in the mid-50s rather than the low 40s. The company sells through three reported regions, Americas, EMEA and APAC, split across a direct-to-consumer channel (own stores and birkenstock.com) and a deliberately rationed B2B wholesale channel. Adjacent lines include Papillio, Birkenstock Natural Skin Care and sleep systems, plus collaborations with Dior, Manolo Blahnik, Stüssy and Ganni that anchor the brand at a higher price point than the $110 Arizona.

The investment picture in October 2026 is a growth story with a currency and tariff wrapper around it. Trailing twelve-month revenue reached ~€2.27 billion, and the fiscal third quarter (ended June 30, 2026) brought revenue of roughly ~€720 million, up ~13% year over year, while earnings per share of ~0.74 landed just short of the ~0.76 consensus. That followed a fiscal second quarter where revenue was ~€618 million, up ~14% in constant currency but only ~8% as reported, and net profit fell ~22% to ~€82 million on FX translation, incremental US tariffs on European-made footwear and channel mix. Trailing net income is ~€336 million on a ~14.8% net margin, below the prior year, because the top line is intact while the reported earnings line absorbs the friction. The shares closed at ~$34.34 on October 16, 2026, down ~17.8% year to date and ~18.9% over one year, for a market cap of ~$5.7 billion and ~16x trailing earnings, well below the multiple at IPO. L Catterton and Financière Agache still hold a controlling stake. Fiscal fourth quarter and full-year results (quarter ending September 30, 2026) are the next report, with consensus near ~€608 million of revenue for the quarter.

Currency is the single largest gap between the operating result and the reported one: the company reports in euros, so dollar weakness turned ~14% constant-currency growth into ~8% reported growth and cut net profit ~22% in the fiscal second quarter, and trailing earnings growth is still about -13% year over year. US tariffs on EU-made footwear were a stated ~100 basis point gross-margin headwind in the fiscal third quarter and ~50 basis points in the fourth, and because production cannot be shifted out of Germany without breaking the Made in Germany positioning, there is no easy sourcing workaround. This is a single-brand company with no diversification if sandal and clog demand cools, and the Boston clog specifically is now the growth driver that a fashion cycle could turn against; Williams Trading downgraded the stock to Sell with a $27 target on October 16, 2026, against an average analyst target near ~$50. Cheap lookalikes from Skechers, Amazon sellers and private-label retailers compete directly on the footbed silhouette at a third of the price. Balance sheet debt of ~€1.93 billion against ~€694 million of cash is meaningful for a consumer brand. L Catterton and Financière Agache retain control, so minority holders have limited influence and any secondary sale is a supply overhang; the Middle East conflict alone reduced EMEA revenue by roughly €6 million in the fiscal second quarter, showing how exposed the wholesale footprint is to regional disruption.

21 analysts publish price targets on BIRK, averaging $50.67 against a $35.63 price as of November 2026, or +42.2%. The published targets run from $26.99 to $76.39, a wide spread, and the ratings split 18 buy, 4 hold, 1 sell. Over the last six months there have been 4 raises and 3 cuts among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full BIRK forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on Birkenstock Holding plc. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Closed-toe silhouettes extend the selling season. The Boston clog and the shearling-lined variants turned a spring and summer sandal brand into something that sells in December, which is why fiscal first quarter revenue grew ~18% in constant currency on holiday demand. The most optimistic published target, $76.39, assumes this works close to its best case.

The case against. Currency is the single largest gap between the operating result and the reported one: the company reports in euros, so dollar weakness turned ~14% constant-currency growth into ~8% reported growth and cut net profit ~22% in the fiscal second quarter, and trailing earnings growth is still about -13% year over year. The most pessimistic target, $26.99, is roughly what BIRK is worth if this bites instead.

Read the full bull and bear case on BIRK, including what would have to change to break either one. Walnut is not an investment adviser.

No. Birkenstock Holding plc (BIRK) has not split its stock in the last 10 years. The statement covers only the window we check, so an older split in the company’s history is possible. It also matters less than it once did: fractional shares mean a high price per share no longer keeps smaller investors out, which removed most of the practical reason to split.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Birkenstock Holding plc's investor relations page or your broker.

• Revenue (TTM): ~€2.27 billion (reports in euros; fiscal year ends September 30)
• Latest quarter revenue growth: ~13% year over year (fiscal Q3 2026, quarter ended June 30, 2026)
• Margins (TTM): ~57% gross, ~29% operating, ~15% net
• Net income (TTM): ~€336 million; latest quarter EPS ~0.74 vs ~0.76 consensus
• P/E: ~16x trailing, ~12.6x forward
• Market cap: ~$5.7 billion at ~$34.34 (October 16, 2026)
• Fiscal 2026 consensus: ~€2.35 billion revenue, ~1.95 EPS; fiscal 2027 ~€2.67 billion
• Dividend: None

At ~$34 the stock trades at ~16x trailing and ~12.6x forward earnings, roughly 2.5x sales and ~11.8x EV/EBITDA, a discount to the premium-brand multiple it carried at the $46 IPO. Fiscal 2025 closed at ~€2.1 billion of revenue with ~€348 million of net income, and fiscal 2026 has kept double-digit top-line growth while tariffs, FX and a heavier wholesale mix held reported earnings back. Consensus expects earnings per share to rise ~25% in fiscal 2027, so the valuation now rests on that margin recovery.

Other names that sit close to BIRK: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. They are useful if you want to spread one thesis across several tickers.

There are three common ways to get BIRK exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so BIRK sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where BIRK fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

BIRK is a rare case of a heritage brand compounding volume, price and geography at once, with the euro reporting currency and US tariff line deciding how much of that reaches the reported result. In October 2026 the market is pricing it at ~13x forward earnings, about a third below its IPO price, so the debate has moved from whether the brand grows to whether margins recover.

Whether BIRK is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is BIRK a buy or a sell?, and where the stock could go from here in the BIRK stock forecast.

For income investors, whether BIRK pays a dividend and how the payout looks is covered in does BIRK pay a dividend? And to weigh BIRK against a peer, read the full side-by-side comparisons: BIRK vs CROX and BIRK vs DECK.